Engineering an aldehyde dehydrogenase toward its substrates, 3-hydroxypropanal and [PMID: 29214999] Laboratory literature summary: Engineering an aldehyde dehydrogenase toward its substrates, 3-hydroxypropanal and NAD(+), for enhancing the production of
Damms A, Bischoff SC: Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases
While some healthcare providers continue to prescribe compounded peptides, the FDA peptide warning maintains that patients should be aware of the uncertainties surrounding these products and the potential risks associated with their use
Be cautious if a product promises stem-cell activation or full follicle regeneration
Consult a qualified healthcare professional for medical guidance.
In these situations, patients may have high B12 on blood work but still exhibit neurological symptoms of deficiency (tingling, numbness, cognitive changes)